Tiziana Life Sciences Attends 10th Joint ACTRIMS-ECTRIMS Meeting

• Tiziana Life Sciences management will attend the 10th joint ACTRIMS-ECTRIMS meeting in Toronto, Oct. 21-23, 2026.
• Representatives will discuss intranasal foralumab’s INFORM-MS trial in non-active secondary progressive multiple sclerosis, alongside collaboration and business development opportunities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tiziana Life Sciences Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610210700OMX_____CNEWS_EN_GNW9849550_en) on October 21, 2026, and is solely responsible for the information contained therein.